Liver Disease
Conference Coverage
Normothermic machine perfusion found to salvage fatty livers for transplantation
SAN FRANCISCO – Technique enables clinicians to “test drive” organ’s viability prior to transplantation.
Conference Coverage
Skin rashes often accompany drug-induced liver injury
SAN FRANCISCO – A survey of drug-induced liver and skin injuries finds they often co-occur and identifies some classes of drugs associated with...
Conference Coverage
Medicaid patients have higher MELD scores at time of liver transplantation
SAN FRANCISCO – These higher MELD scores may reflect delays in referral for liver transplantation evaluation.
Conference Coverage
The Liver Meeting 2018: Hepatitis B novel therapies debrief – key abstracts
SAN FRANCISCO – Novel hepatitis B therapies generated excitement at The Liver Meeting, according to Dr. Jordan Feld.
From the Journals
Routine markers predicted histologic response to obeticholic acid in NASH
Significant predictors included baseline nonalcoholic fatty liver disease activity score greater than 5, baseline triglycerides up to 154 mg/dL,...
Conference Coverage
Hep C–infected livers are safe for transplant
SAN FRANCISCO – An analysis shows no difference in graft survival or overall survival when a donated liver is...
Conference Coverage
Risk of cancer in NAFLD is 91% higher than in control subjects
SAN FRANCISCO – The observed increase is highest in gastrointestinal cancer subjects.
Conference Coverage
Chronic liver disease independently linked to increased risk of falls
SAN FRANCISCO – Subjects with viral hepatitis had the strongest association with a history of falls.
News
FDA approves pembrolizumab for sorafenib-intolerant HCC patients
Approval was based on an objective response rate of 17% in KEYNOTE-224, a single-arm trial of 104 patients with hepatocellular carcinoma who were...
Conference Coverage
About 13% of liver transplant recipients affected by PTSD
MELD scores had no association with PTSD in this analysis.